Skip to main content

ADVERTISEMENT

Rebecca Mashaw

FDA alert
News
06/28/2024
The device can provide results in an hour from a fingertip blood test.
The device can provide results in an hour from a fingertip blood test.
The device can provide results...
06/28/2024
Gastroenterology
FDA alert
FDA Alert
06/20/2024
The approval makes risankizumab the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and Crohn's disease.
The approval makes risankizumab the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and Crohn's disease.
The approval makes risankizumab...
06/20/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
06/14/2024
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the...
06/14/2024
Gastroenterology
Bruce Sands
Conference Coverage
10/25/2022
Bruce E. Sands, MD, MS, FACG, gave the J. Edward Berk Distinguished Lecture at the American College of Gastroenterology Scientific Meeting on October 25, reviewing the progress of therapies for inflammatory bowel disease (IBD) and emerging...
Bruce E. Sands, MD, MS, FACG, gave the J. Edward Berk Distinguished Lecture at the American College of Gastroenterology Scientific Meeting on October 25, reviewing the progress of therapies for inflammatory bowel disease (IBD) and emerging...
Bruce E. Sands, MD, MS, FACG,...
10/25/2022
Advances in Inflammatory Bowel Disease Network